[Use of doxazosin (Cardura-Pfizer), alpha 1-adrenoreceptor antagonist, in treatment of hypertension in patients with diabetes].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Grzeszczak W;Grzeszczak W
  • Source:
    Wiadomosci lekarskie (Warsaw, Poland : 1960) [Wiad Lek] 1998; Vol. 51 Suppl 2, pp. 5-10.
  • Publication Type:
    English Abstract; Journal Article; Review
  • Language:
    Polish
  • Additional Information
    • Transliterated Title:
      Zastosowanie doksazosyny (Cardura-Pfizer), leku blokujacego receptory alpha 1-adrenergiczne, w leczeniu nadciśnienia tetniczego u chorych na cukrzyce.
    • Source:
      Publisher: Aluna Publishing Country of Publication: Poland NLM ID: 9705467 Publication Model: Print Cited Medium: Print ISSN: 0043-5147 (Print) Linking ISSN: 00435147 NLM ISO Abbreviation: Wiad Lek Subsets: MEDLINE
    • Publication Information:
      Publication: Konstancin Jeziorna : Aluna Publishing
      Original Publication: Warszawa : Pánstwowy Zakład Wydawnictw Lekarskich, [1960-
    • Subject Terms:
      Adrenergic alpha-Antagonists/*therapeutic use ; Diabetic Angiopathies/*drug therapy ; Doxazosin/*therapeutic use ; Hypertension/*drug therapy; Adult ; Aged ; Animals ; Diabetic Angiopathies/complications ; Humans ; Hypercholesterolemia/complications ; Hypertension/complications ; Male ; Middle Aged ; Prostatic Hyperplasia/complications
    • Abstract:
      Doxazosin (Cardura-Pfizer) is a alpha 1-adrenoreceptor antagonist. This drug significantly decreases the blood pressure in subjects with hypertension. Despite decreasing blood pressure, doxazosin has a beneficial effect on many disorders observed in subjects with diabetes mellitus. Doxazosin 1) improves the regulation of lipids disturbances, 2) improves tissue sensitivity to insulin, 3) decreases the frequency of sexual disorders. In this situation Doxazosin is a good choice in the treatment of hypertension in diabetic subjects, in subjects with hypertension and hypercholesterolemia, with left ventricular hypertrophy, in old male subjects with hypertension and benign prostatic hypertrophy.
    • Number of References:
      23
    • Accession Number:
      0 (Adrenergic alpha-Antagonists)
      NW1291F1W8 (Doxazosin)
    • Publication Date:
      Date Created: 19980801 Date Completed: 19980901 Latest Revision: 20131121
    • Publication Date:
      20231215
    • Accession Number:
      9686527